IMS-treatment and Canalis Carpi Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Carpal tunnel syndrome is a condition in which the median nerve is compressed at the wrist, leading to paresthesias, numbness and muscle weakness in the hand. Treatment of the condition often involves surgery.

In this study we wish to se if there is an effect of using intramuscular stimulation (IMS) to release the tension of nervus medianus in the lower arm. The study will be performed by randomization to IMS of musculus pronator teres or a control ("Scam IMS treatment" to the acupuncture point Li11). The two insertion points are approximately 1cm apart in the lower arm.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Treatment of Carpal Tunnel Syndrome Using Thumb Pressure Along the Median Nerve

NCT00634699

Carpal Tunnel Syndrome

COMPLETED PHASE1/PHASE2

Dry Needling and Rehabilitatin Carpal Tunnel Syndrome

NCT06358326

Dry Needling Carpal Tunnel Syndrome Myofacial Pain

COMPLETED NA

The Effect of Perineural Injection Therapy in Patients With Carpal Tunnel Syndrome

NCT02809261

Carpal Tunnel Syndrome

COMPLETED NA

Efficacy of Ultrasound-guided Transverse Carpal Ligament Release for Carpal Tunnel Syndrome

NCT06251674

Carpal Tunnel Syndrome

COMPLETED NA

The Treatment of the Median Nerve for the Elimination of the Symptoms Associated With the Carpal Tunnel Syndrome

NCT00634738

Compression Neuropathy, Carpal Tunnel

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The most important outcome measure is ultra sound measured diameters for nervus medianus in the carpal tunnel

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Needle in acupuncture point Li11

Acupuncture needle in the acupuncture point Li11

Group Type SHAM_COMPARATOR

Needle in acupuncture point Li11

Intervention Type DEVICE

Acupuncture needle in acupuncture point Li11

IMS of musculus pronator teres

Acupuncture needle in musculus pronator teres

Group Type EXPERIMENTAL

IMS of the musculus pronator teres

Intervention Type DEVICE

Acupuncture needle in musculus pronator teres

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Needle in acupuncture point Li11

Acupuncture needle in acupuncture point Li11

Intervention Type DEVICE

IMS of the musculus pronator teres

Acupuncture needle in musculus pronator teres

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Needles Needles

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Canalis Carpi Syndrome verified by ultrasound and clinically
* Both genders
* Age from 18 to 67

Exclusion Criteria

* Negative neurophysiology result.
* Epilepsy,
* Heart disease,
* Rheumatism
* Unstable angina pectoris,
* Metal -allergy,
* Needle- phobia,
* Infection
* Hemophilia
* Cognitive problems

Minimum Eligible Age

18 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes